Brenton Scott Email
President and Chief Operating Officer . Pulmotect
How to contact Brenton Scott
Join and see Brenton's contact info for free!Current Roles
Employees:
11Revenue:
$1.7MAbout
Pulmotect has developed PUL-042, an inhaled therapeutic which aims to boost the body's innate immune system resulting in highly-targeted lung protection against all major classes of pathogens including bacteria, fungi, and viral pathogens. Pulmotect’s initial market focus is on the reduction of chronic obstructive pulmonary disease (COPD) exacerbations, which are characterized by an acute worsening of symptoms mostly precipitated by a bacterial or viral infection.Pulmotect Address
3990 Essex LaneHouston, TX
United States